OCT 17, 2020 8:00 AM PDT

Imaging Innovation Set to Ease the Pain of Osteoarthritis

WRITTEN BY: Tara Fernandez

In osteoarthritis, the joint cartilage that cushions bones begins to break down, causing debilitating pain and stiffness. It’s the most common form of degenerative joint disease, affecting almost 240 million people around the world.

Australian researchers have developed a cutting edge imaging technique to visualize the signs of osteoarthritis. Using mass spectrometry imaging, the scientists were able to paint a molecular picture of osteoarthritic cartilage, revealing that damaged tissue had numerous signature patterns of the expression of different sugars. The study was published in the International Journal of Molecular Sciences.

"It is one of the most common degenerative joint diseases, yet there are limited diagnostic tools, few treatment options and no cure," said lead scientist Paul Anderson from the University of South Australia.

For now, diagnostics rely on biomarkers present in bodily fluids — a test that lacks both precision and accuracy. The new imaging platform can map changes on molecular level in different anatomical regions, thus helping to inform optimal clinical strategies to slow the progression of the condition. Mass spectrometry already has a stellar track record in diagnostic settings, demonstrating its efficacy in identifying cancer biomarkers, for example.

“To date, diagnosing osteoarthritis has relied heavily on x-rays or MRI, but these provide limited information and don't detect biomolecular changes that signal cartilage and bone abnormalities,” said Olivia Lee, a graduate student who contributed to the study.

“By contrast, alternative imaging methods such as MSI can identify specific molecules and organic compounds in the tissue section." Osteoarthritis is a heavy burden on healthcare systems and patients due to loss of work productivity, costs of treatments, and the diminished quality of life during osteoarthritis flare ups. These next generation diagnostic technologies are a light at the end of the tunnel for transforming osteoarthritis standards of care.

Sources: International Journal of Molecular Sciences, University of South Australia.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
FEB 15, 2021
Clinical & Molecular DX
Asking Patients the Right Questions About Their Symptoms
FEB 15, 2021
Asking Patients the Right Questions About Their Symptoms
A patient is admitted to the hospital after experiencing chest pains. What are the right questions that hospital staff a ...
MAR 25, 2021
Clinical & Molecular DX
Police Speeding Radar Technology Used to Catch Antibiotic-Resistant Bacteria
MAR 25, 2021
Police Speeding Radar Technology Used to Catch Antibiotic-Resistant Bacteria
Doppler radars are used by cops to catch speeding drivers, in spacecraft navigation, and for forecasting the weather. No ...
APR 02, 2021
Genetics & Genomics
A New Neurodevelopmental Disorder is ID'ed
APR 02, 2021
A New Neurodevelopmental Disorder is ID'ed
Researchers have identified a genetic disease that causes neurodevelopmental disorders in some affected kids. The diseas ...
APR 13, 2021
Clinical & Molecular DX
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
APR 13, 2021
A Color-Changing "Invisible Tattoo" for Long-Term Health Monitoring
German researchers have developed an innovative method for continuously tracking and monitoring biomarkers and drugs cir ...
JUN 08, 2021
Genetics & Genomics
Primers and Probes to Assay for SARS-CoV-2 Variants in Research Samples
JUN 08, 2021
Primers and Probes to Assay for SARS-CoV-2 Variants in Research Samples
Today, many scientists are investigating SARS-CoV-2 variants in their research projects. In order to facilitate screenin ...
JUN 15, 2021
Clinical & Molecular DX
An Early Warning System for Type 1 Diabetes in Children
JUN 15, 2021
An Early Warning System for Type 1 Diabetes in Children
In type 1 diabetes, or T1D, the body’s own immune system mistakenly launches an aggressive attack on insulin-produ ...
Loading Comments...